Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 5
Submit an article Journal homepage
751
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Baricitinib for the treatment of atopic dermatitis

Amelia Meloa Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal
,
Jose Manuel Carrascosab Department of Dermatology, Germans Trias i Pujol University Hospital (HUGTP), Autonomous University of Barcelona (UAB), Badalona, SpainORCID Iconhttps://orcid.org/0000-0003-4266-0771
ORCID Icon &
Tiago Torresa Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal;c Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, PortugalCorrespondence[email protected] [email protected]
Pages 2404-2413 | Received 19 Jul 2021, Accepted 08 Aug 2021, Published online: 23 Aug 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria E. Montez-Rath, Robert Lubwama, Kris Kapphahn, Albee Y. Ling, Robert LoCasale, Lacey Robinson, Karen J. Chandross & Manisha Desai. (2022) Characterizing real world safety profile of oral Janus kinase inhibitors among adult atopic dermatitis patients: evidence transporting from the rheumatoid arthritis population. Current Medical Research and Opinion 38:8, pages 1431-1437.
Read now

Articles from other publishers (4)

Fei Liu, Bin Wang, Yanlong Liu, Wei Shi, Zhongyuan Hu, Xiayun Chang, Xujing Tang, Ying Zhang, Hongjiang Xu & Ying He. (2023) Design, synthesis and biological evaluation of novel N-(methyl-d) pyridazine-3-carboxamide derivatives as TYK2 inhibitors. Bioorganic & Medicinal Chemistry Letters 86, pages 129235.
Crossref
Bin Wang, Shuaixi Pan, Yue Yao, Linxi Zeng & Guoqiang Zhang. (2022) Efficacy and safety of baricitinib for the treatment of moderate‐to‐severe atopic dermatitis: A systematic review and meta‐analysis of randomized clinical trials. Clinical and Experimental Pharmacology and Physiology 49:11, pages 1139-1149.
Crossref
Sheridan M. Hoy. (2022) Baricitinib: A Review in Moderate to Severe Atopic Dermatitis. American Journal of Clinical Dermatology 23:3, pages 409-420.
Crossref
E. V. Svechnikova, S. E. Zhufina & E. Yu. Evdokimov. (2022) Current views on the pathogenesis and treatment of atopic dermatitis in adults. Experience with the JAK inhibitor baricitinib in patients with moderate to severe atopic dermatitis. Meditsinskiy sovet = Medical Council:6, pages 193-201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.